Jun 15, 2020
One Drop Announces Long-Term Outcomes Forecasts For Diabetes-Related Biomarkers And Overnight Hypoglycemia Predictions For CGM Users
Apr 23, 2020
U.S. FDA grants orphan drug designation to AmideBio's glucagon analog for the treatment of congenital hyperinsulinism
Feb 21, 2020
Study from Ascensia Demonstrates Impact of BGMS Selection on Glycemic Control when Using a Diabetes Management App
Nov 04, 2019
Positive results in Phase 3 trial for Toujeo® in children and adolescents with type 1 diabetes
Sep 23, 2019
Discontinuing insulin for older adults with type 2 diabetes
Sep 13, 2019
Abbott's Revolutionary FreeStyle® Libre System Now Reimbursed in the Two Largest Provinces in Canada
Sep 10, 2019
New global survey highlights impact of diabetes management on family members
Sep 09, 2019
Children's Hospital of Philadelphia Hosts Weekend of Education for Patients and Clinicians
Aug 12, 2019
DarioHealth® Clinical Study Data Shows the Dario Membership Program Assists Diabetes Patients in Achieving Pre-Diabetic Blood-Glucose Levels and Consistent In-Range Measurements
Jul 24, 2019
BAQSIMI(TM) (glucagon) Nasal Powder 3 mg, the First and Only Nasally Administered Glucagon to Treat Severe Hypoglycemia in Adults and Children with Diabetes Ages Four Years and Older, Approved by FDA
Jun 17, 2019
Eiger Announces Breakthrough Therapy Designation Granted by FDA for Avexitide for Treatment of Post-Bariatric Hypoglycemia (PBH)
Jun 10, 2019
Access to Continuous Glucose Monitors in Pediatric Diabetes Populations Improves Glycemic Control, Reduces Hypoglycemia and Improves Satisfaction with Diabetes Care and Technology Use
Jun 08, 2019
The iLet Bionic Pancreas Increased Time in Range for Adults with Type 1 Diabetes
Mar 25, 2019
Eiger BioPharmaceuticals Announces Oral Presentation of Phase 2 PREVENT Study Results of Avexitide in Post-Bariatric Hypoglycemia at Endocrine Society Meeting (ENDO) 2019
Feb 15, 2019
Senseonics Announces Partnership with Geo-Med to Provide Veterans Access to Eversense CGM
Feb 04, 2019
Eiger BioPharmaceuticals Announces Oral Presentation of Phase 2 PREVENT Study of Avexitide in Post-Bariatric Hypoglycemia (PBH) at Upcoming Endocrine Society (ENDO) Meeting 2019 in New Orleans
Nov 08, 2018
Study Presented at Diabetes Technology Meeting Showing That Usage of Contour®Diabetes App May Reduce the Chance of Hypoglycemic and Hyperglycemic Events in People With Diabetes
Oct 30, 2018
Advocate by Pharma Supply, Inc. Launches New Form of Rapid Glucose Delivery for Low Blood Sugar (Hypoglycemia)
Aug 09, 2018
I-Mab's Announces China Clinical Trial Approval of Long-acting hGLP-1 to Treat Type 2 Diabetes
Jun 25, 2018
Livongo for Diabetes Achieves Sustained Positive 12-Month Outcomes for People with Type 2 Diabetes, New Research Finds